Skip to main content
. 2004 Oct;48(10):3711–3714. doi: 10.1128/AAC.48.10.3711-3714.2004

TABLE 2.

In vitro activities of the combinations of compound 1 and-DDS, and chlorcyloguanil-DDS against P. falciparum V1S

Drug namea Drug IC50 (nM) in presence of DDS sFIC
Compound 1 0.08 (9,200)b 0.060
0.09 (6,100) 0.043
0.12 (4,600) 0.038
CCG 15.40 (9,200) 0.27
17.90 (6,100) 0.29
24.40 (4,600) 0.37
a

The IC50s of compound 1, CCG, and DDS alone were 9, 71, and 184, 300 nM, respectively.

b

Values in parentheses represent the concentrations of DDS (in nanomolar).